A Multi-Centered Study of the Long-Term Effect of Salmeterol and Albuterol in Cystic Fibrosis - Related Studies

A Multi-Centered Study of the Long-Term Effect of Salmeterol and Albuterol in Cystic Fibrosis

This study has been suspended.

Study NCT00005110. Last updated on June 23, 2005. Information provided by National Center for Research Resources (NCRR)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Cystic Fibrosis

2	Additional conditions recognized in this trial
		Fibrosis

3	More general conditions related to this trial
		Digestive System Diseases
		Genetic Diseases, Inborn
		Infant, Newborn, Diseases
		Lung Diseases
		Pancreatic Diseases
		Pathologic Processes
		Respiratory Tract Diseases

4	Interventions listed in this trial
		Salmeterol
		Albuterol

5	More general drug interventions related to this trial
		Adrenergic Agents
		Adrenergic Agonists
		Adrenergic beta-Agonists
		Anti-Asthmatic Agents
		Autonomic Agents
		Bronchodilator Agents
		Molecular Mechanisms of Pharmacological Action
		Neurotransmitter Agents
		Peripheral Nervous System Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Reproductive Control Agents
		Respiratory System Agents
		Therapeutic Uses
		Tocolytic Agents

6	Sponsors listed in this trial
		National Center for Research Resources (NCRR)